Skip to main content

Torpedo Therapeutics

This company develops micro- and nano-fabricated electrode leads for high-precision deep brain stimulation (DBS) that offer single-neuron resolution targeting. They integrate these leads with a control chip and a machine learning platform for closed-loop sensing and automated parameter adjustment based on neural activity. This technology aims to reduce off-target side effects and eliminate the need for frequent, manual DBS reprogramming.

Traction 3/10
HQ unknown
Founded 20186300+ followers
  • Artificial Intelligence
  • Biotechnology
  • Hardware
  • Healthcare Technology
Updated 7 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

1 founder

Ingrid van Welie

Founder and CEO

Product

Problem

Existing deep brain stimulation (DBS) therapies utilize large electrodes that lack spatial precision, leading to off-target stimulation and associated side effects. Continuous, open-loop stimulation protocols can also result in decreased responsiveness over time, necessitating frequent clinical reprogramming and increasing the burden on patients.

Solution

Torpedo Therapeutics is developing high-precision, closed-loop DBS devices that leverage micro- and nano-fabrication technologies to create ultra-small electrodes. These micro-electrodes enable stimulation with single-neuron precision, minimizing off-target effects and potential side effects. The system incorporates real-time neural activity sensing and a machine learning-driven data analysis platform to automatically adjust stimulation parameters, reducing the need for frequent reprogramming and optimizing long-term efficacy. This closed-loop approach aims to provide more personalized and adaptive therapy for neurological disorders.

Target Audience

The primary target audience includes patients with Parkinson’s disease, Essential Tremor, Dystonia, and drug-resistant Epilepsy, as well as clinicians specializing in deep brain stimulation therapies.

Features

  • Micro-electrode leads with individual electrodes 150 times smaller than existing DBS electrodes
  • High spatial resolution stimulation capable of single-neuron precision
  • Closed-loop sensing and stimulation platform for real-time neural activity monitoring
  • Machine learning-driven data analysis platform for predictive assessments
  • Automated adjustment of stimulation parameters based on local neural activity
  • Electronic chip for signal readout and stimulation control, designed to replace bulky implantable pulse generators
This profile is AI-generated and may contain inaccuracies.